Inventor · disambiguated record
David J. Lloyd
Also filed as: LLOYD DAVID · LLOYD DAVID J · LLOYD DAVID JOHN
5 granted patents·9 pending applications·18 citations·filing 2005–2025
75Inventor score
Top patents by PatentIndex Score
14 records- 0191US10294303B2Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonistsAMGEN INC·Filed 2016·Granted May 21, 2019·12 cites·14 claims
- 0286US12252540B2Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)AMGEN INC·Filed 2021·Granted Mar 18, 2025·1 cites·5 claims
- 0386US11046774B2Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonistsAMGEN INC·Filed 2019·Granted Jun 29, 2021·5 cites·18 claims
- 0479US2025092025A1Gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their useCARMOT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0578US2025319196A1Method of treating or ameliorating metabolic disorders using antagonistic binding proteins for gastric inhibitory peptide receptor (gipr)/glp-1 receptor agonist fusion proteinsAMGEN INC·Filed 2025·Application pending·0 cites
- 0678US2024261421A1Method of treating or ameliorating metabolic disorders using antagonistic binding proteins for gastric inhibitory peptide receptor (gipr)/glp-1 receptor agonist fusion proteinsAMGEN INC·Filed 2024·Application pending·0 cites
- 0771US2025376529A1Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (gipr) in combination with glp-1 agonistsAMGEN INC·Filed 2025·Application pending·0 cites
- 0870US2023089073A1Gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their useCARMOT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0970US2024252492A1Gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their useCARMOT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1065US12465652B2Method of treating or ameliorating metabolic disorders using antagonistic binding proteins for gastric inhibitory peptide receptor (GIPR)/GLP-1 receptor agonist fusion proteinsAMGEN INC·Filed 2018·Granted Nov 11, 2025·0 cites·20 claims
- 1159US12435149B2Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonistsAMGEN INC·Filed 2018·Granted Oct 7, 2025·0 cites·49 claims
- 1247US2025333742A1Compositions and methods for treating metabolic dysfunction-associated steatotic liver diseaseINSITRO INC·Filed 2025·Application pending·0 cites
- 1347US2022403038A1Method of treating or ameliorating cushing's syndrome using binding proteins for gastric inhibitory peptide receptor (gipr)AMGEN INC·Filed 2020·Application pending·0 cites
- 1440US2008250516A1Prohormone Convertase 1 Mutation Associated with ObesityIRM LLC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David J. Lloyd files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →